Yasra Badi, Mohamed Hammad, Abdelrahman G Tawfik, Mona Muhe Eldeen Eshag, Mahmoud M Elhady, Khaled Mohamed Ragab, Anas Zakarya Nourelden, Mohamed Hesham Gamal, Ahmed Hashem Fathallah
BACKGROUND: More than six million people died due to COVID-19, and 10-15% of infected individuals suffer from post-covid syndrome. Corticosteroids are widely used in the management of severe COVID-19 and post-acute COVID-19 symptoms. This study synthesizes current evidence of the effectiveness of inhaled corticosteroids (ICS) on mortality, hospital length-of-stay (LOS), and improvement of smell scores in patients with COVID-19. METHODS: We searched Embase, Web of Science, PubMed, Cochrane Library, and Scopus until Aug 2022...
2023: Canadian Journal of Respiratory Therapy: CJRT